Delivery Order SPE2DB24D6039-SPE2DB25FLEPM
Award Date 9/24/25
Potential Completion Date 9/25/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,892.00 delivery order to AmerisourceBergen Drug Corp for Jolessa 0.15 mg–0.03 mg tablets (91-count supply) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order was placed under a child contract vehicle without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a $1,867.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jolessa 0.15 mg-0.03 mg tablets (91-count). This non-set-aside contract, issued on July 11, 2025, with an ultimate completion date of July 14, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The place of performance is listed as Conshohocken, PA 19428, where AmerisourceBergen Drug Corp maintains its corporate...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jolessa 0.15 mg-0.03 mg tablets. The $1,109.49 firm fixed-price contract has an ultimate completion date of October 8, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,336.95 to AmerisourceBergen Drug Corp for the supply of Jolessa 0.15 mg-0.03 mg tablets (91 count) under a firm fixed-price contract. The delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, carries no set-aside designation and was competitively awarded. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, the prime contractor, for the delivery of Jolessa 0.15 mg-0.03 mg tablets. The contract is a firm fixed price delivery order with a ceiling value of $1,019.54 and a performance period through March 25, 2024. AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation, is providing these pharmaceutical products to support military...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,027.83, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Jolessa 0.15 mg-0.03 mg tablets, a pharmaceutical product, with a ceiling value of $1,178.45 and a performance period ending on June 26, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,104.25 firm-fixed-price contract is for the supply of Jolessa 0.15 mg-0.03 mg tablets. The contract has an ultimate completion date of April 17, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,334.60, is for the delivery of the prescription medication Jolessa 0.15 mg-0.03 mg tablet. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 1, 2023. The contract is not designated as a set-aside award. AmerisourceBergen holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,727.16, is for the delivery of the prescription medication JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract has an ultimate completion date of September 12, 2022 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a...